Europe Pharmaceutical Logistics Market Size

Europe Pharmaceutical Logistics Market Analysis

The Europe Pharmaceutical Logistics Market size is estimated at USD 86.89 billion in 2024, and is expected to reach USD 105.31 billion by 2029, growing at a CAGR of 3.92% during the forecast period (2024-2029).

• The demand for pharmaceutical logistics in Europe is mainly driven by the increasing demand for drugs and vaccines, fueled by the COVID-19 pandemic and increasing investments by leading pharmaceutical firms. The COVID-19 pandemic increased the trade of conventional and over-the-counter (OTC) drugs in Europe. Enhancement in the production rate of biologics, hormone medications, vaccines, complex proteins, and temperature-specific byproducts requiring cold chain shipment also witnessed significant growth in the European pharmaceutical logistics market. There is a strong and competitive pharmaceutical industry in Europe.
• Moreover, increasing demand for cellular therapies, vaccines, and blood products in the pharmaceutical industry is driving the growth of the region's pharmaceutical logistics market. The increase in demand for reverse logistics in the pharmaceutical sector, the rise in demand for temperature-sensitive pharmaceutical drugs, and the increase in the use of RFID technologies for pharmaceutical logistics are upcoming trends in the pharmaceutical logistics market in Europe.
• The growing pharmaceutical sales are expected to propel the growth of the healthcare logistics market. Increasing sales of pharmaceuticals are expected to boost the demand for logistics as the pharmaceutical products or drugs should be stored and transported to pharmacies, drug stores, and others, thus increasing the demand for transportation or healthcare logistics.